Veteran AI and SaaS product executive to advance Duck Creek’s AI-driven product strategy and platform innovation Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty P&C and general insurance, today announced the appointment of Jose Lazares as Chief Product Officer (CPO). In this role, Lazares will lead Duck Creek’s […]
The generously portioned craveable combo, designed for those who love crispy, cheesy edges, gets a hometown boost from Lions star Amon-Ra St. Brown Little Caesars today announced the launch of Detroit-Style Slices-N-Stix, a new single-serve meal option that brings together two of the brand’s most iconic offerings in one irresistible package. Beginning January 12, customers
— Chtrbox establishes Dubai as its inaugural global operational hub and gateway to the Middle East — Expansion led by Raj Mishra, former Country Head of TikTok India, leveraging his experience in building large-scale creator ecosystems — Initiative aims to connect Indian and Middle Eastern creator economies, enabling talent exchange and brand collaborations across regions
Powered by extended runtime, enhanced edge compute and even sharper vision, Tally 4.0 delivers deeper shelf coverage and real-time data insights at enterprise scale to power retail’s next era. Simbe, the global leader in retail shelf digitization and store intelligence, today announced the launch of Tally 4.0, the most advanced generation of its shelf-scanning robot
Designation encompasses treatment of pancreatic cancer, including use in combination with immune checkpoint inhibitors Novita Pharmaceuticals, Inc. (“Novita”), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary fascin inhibitor technology, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational
Fundstrat Capital today announced another significant milestone for its flagship Fundstrat Granny Shots US Large Cap ETF (NYSE: GRNY), which has surpassed $4 billion in assets under management (AUM). The rapid growth solidifies GRNY’s position as one of the fastest-growing actively managed equity ETFs in the market.1 “In just a little over one year since
Symphony Talent’s 2026 Talent Acquisition Outlook Report reveals how leading organizations are pairing AI adoption with full-funnel visibility, internal mobility, and consistent brand activation to hire smarter and faster. Symphony Talent, a global leader in talent acquisition solutions, today announced the release of its 2026 Talent Acquisition Outlook Report, a comprehensive analysis of the trends,
AlphaSense, the AI platform redefining market intelligence for the business and financial world, today announced it is sponsoring Fierce JPM Week, one of the world’s most influential healthcare and biotech events, as industry leaders navigate imperatives to redefine business models, understand policy reforms, and dissect new economics of drug development alongside strategizing for advances in
Breakthrough T1D award will fund project to advance fully automated insulin delivery Invictus Therapeutics, a biotechnology company developing next-generation insulin analogs engineered for automated insulin delivery systems, today announced it has received an Industry Discovery and Development Partnership (IDDP) award from Breakthrough T1D (formerly JDRF), the leading global type 1 diabetes (T1D) research and advocacy
Key Highlights: — Sebela Pharmaceuticals® submitted its New Drug Application (NDA) for tegoprazan on January 9, 2026. The NDA seeks approval for three indications: Non-Erosive Reflux Disease (NERD), Erosive Esophagitis (EE) Healing, and EE Maintenance — Once approved, tegoprazan will be the first Potassium-Competitive Acid Blocker (P-CAB) to demonstrate superiority in EE healing across all